Naoko Sato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Naoko Sato has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ai Yanagihara
School of Regional Innovation and Social Design Engineering, Kitami Institute of Technology, Kitami 090-8507, Japan
1 shared publication - Anuu Zorig
School of Regional Innovation and Social Design Engineering, Kitami Institute of Technology, Hokkaido 090-8507, Japan
1 shared publication Atsushi Urano
Department of Pharmacy, Toho University Sakura Medical Center
1 shared publication- Hirofumi Arai
Department of Biotechnology and Environmental Chemistry, Kitami Institute of Technology , Kitami, Hokkaido
1 shared publication - Hiroyuki Tanaka
The Institute of Scientific and Industrial Research, Osaka University, Ibaraki, Osaka 567-0047, Japan
1 shared publication Kaori Izawa
Department of Pharmacy, Toho University Sakura Medical Center
1 shared publication
Latest Publications
- Open Access
- 30 September 2023
- Published by The Korean Society of Food Science and Nutrition in Preventive Nutrition and Food Science
- Vol. 28 (3) , 335-346
Effect of Polyphenols in Sea Buckthorn Berry on Chemical Mediator Release from Mast Cells
Shiman Qiu, Anuu Zorig, Naoko Sato, Ai Yanagihara, Tsutomu Kanazawa, Mikako Takasugi, and Hirofumi Arai. Prev Nutr Food Sci 2023;28:335-46. https://doi.org/10.3746/pnf.2023.28.3.335
- 30 September 2023
- Published by The Korean Society of Food Science and Nutrition in Preventive Nutrition and Food Science
- Vol. 28 (3) , 335-346
Open AccessEffect of Polyphenols in Sea Buckthorn Berry on Chemical Mediator Release from Mast Cells
Shiman Qiu, Anuu Zorig, Naoko Sato, Ai Yanagihara, Tsutomu Kanazawa, Mikako Takasugi, and Hirofumi Arai. Prev Nutr Food Sci 2023;28:335-46. https://doi.org/10.3746/pnf.2023.28.3.335
- Open Access
- 1 November 2022
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 142 (11) , 1267-1276
Chemical Stability after Mixing Continuous Infusion Drugs Used to Treat Cardiogenic Shock
During the treatment of cardiogenic shock, various continuous infusion drugs are used simultaneously. However, administration from the same route may result in stability changes due to mixing of drugs. In addition, stability tests after mixing more than three types of drugs have hardly been conducted. In this study, noradrenaline, milrinone, dobutamine hydrochloride, and landiolol hydrochloride were used to evaluate the chemical stability of the mixture. Chemical stability was evaluated by measuring the change in each drug concentration over time and calculating the content. The concentration of each drug was measured using an optimized gradient elution method by HPLC. In a four-drug mixed sample, noradrenaline, milrinone, dobutamine hydrochloride, and landiolol hydrochloride had retention times of 2.1 min, 5.2 min, 9.3 min, and 11.9 min, respectively. The concentration immediately after mixing each drug was almost the same as the theoretical concentration at the time of mixing each drug. Furthermore, noradrenaline, milrinone, and dobutamine hydrochloride concentrations were maintained up to 99% in each drug mixture until 24 h after mixing all the samples. However, the content of landiolol hydrochloride was 90% or less 24 h after mixing, except for two types of mixed solutions with dobutamine hydrochloride. This result suggested that landiolol hydrochloride was being degraded owing to acidic conditions. The results of this study suggest that noradrenaline, milrinone, and dobutamine hydrochloride can be administered from one route, while it is recommended that landiolol hydrochloride be administered from another route.
- 1 November 2022
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 142 (11) , 1267-1276
Open AccessChemical Stability after Mixing Continuous Infusion Drugs Used to Treat Cardiogenic Shock
During the treatment of cardiogenic shock, various continuous infusion drugs are used simultaneously. However, administration from the same route may result in stability changes due to mixing of drugs. In addition, stability tests after mixing more than three types of drugs have hardly been conducted. In this study, noradrenaline, milrinone, dobutamine hydrochloride, and landiolol hydrochloride were used to evaluate the chemical stability of the mixture. Chemical stability was evaluated by measuring the change in each drug concentration over time and calculating the content. The concentration of each drug was measured using an optimized gradient elution method by HPLC. In a four-drug mixed sample, noradrenaline, milrinone, dobutamine hydrochloride, and landiolol hydrochloride had retention times of 2.1 min, 5.2 min, 9.3 min, and 11.9 min, respectively. The concentration immediately after mixing each drug was almost the same as the theoretical concentration at the time of mixing each drug. Furthermore, noradrenaline, milrinone, and dobutamine hydrochloride concentrations were maintained up to 99% in each drug mixture until 24 h after mixing all the samples. However, the content of landiolol hydrochloride was 90% or less 24 h after mixing, except for two types of mixed solutions with dobutamine hydrochloride. This result suggested that landiolol hydrochloride was being degraded owing to acidic conditions. The results of this study suggest that noradrenaline, milrinone, and dobutamine hydrochloride can be administered from one route, while it is recommended that landiolol hydrochloride be administered from another route.